Nemours Children's Hospital, Delaware
Nemours Center for Cancer and Blood Disorders
1600 Rockland Road
Wilmington, DE 19803
Direct phone: (302) 651-4000
Total transplants by cell source
- Marrow: 11
- PBSC: 3
- Cord Blood: 1
- Autologous (PBSC or Marrow): 6
About the center
The objectives of the BBMT program are the following: Assure the quality and safety of care provided to transplant patients. To provide excellent and compassionate care for patients and their families who are under going hematopoietic progenitor cell transplantation. Ensure consistent coordination and continuity of care across all disciplines. Establish a foundation of Continuous Performance Improvement (CPI) that reflects Nemours commitment to quality.
This center has been performing allogeneic transplants since 2001 and has been an NMDP/Be The Match transplant center since July 2010.
Adult - E. Anders Kolb, Emi Caywood, Darcy Hamill, Jonathan Powell
Pediatric - E. Anders Kolb, Emi Caywood, Darcy Hamill, Jonathan Powell
Marrow/PBSC, single cord, and double cord
Cord blood transplants performed on
Other programs and services
Pet Therapy, Music Therapy, School Program, Healing Touch, Child Life, Patient Navigation, Cancer Care Coordinator, Ronald McDonald House, Caregiver programs, family centered rounds, Family Advisory Council, Palliative Care Program.
Overall center survival
Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center.
The survival information we have for this center includes ONLY:
- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2018, 2019, 2020, and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 23 patients.
The actual 1-year survival of these patients is 78.3%.
Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 72.8% and 99.4%.
For help with understanding these statistics, please see Understanding Transplant Outcomes.
For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.
Transplants reported (From January 1, 2020 to December 31st, 2021 as reported by the centers)
|Both marrow & PBSC
Transplants by disease
Number of transplants by age reported from January 1, 2020 to December 31st, 2021 (includes marrow, PBSC and cord blood)
Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants for this disease can be found:
Transplant center resources
Transplant center coordinator:
Be The Match patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
Inside the United States: 1 (888) 999-6743
Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)